Posters

Search for posters by using the search bar below. Clear the search bar to reset your search. 

Poster number Category Name Surname Affiliation Poster Title Search
P01 Clinical trials & new drugs Daria Zygala Laboratory of Genetics and Physiology of Mycobacterium, Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland Evaluation of the influence of natural selection on gyrA and gyrB genes encoding DNA gyrase P01 Clinical trials & new drugs Zygala Evaluation of the influence of natural selection on gyrA and gyrB genes encoding DNA gyrase
P02 Clinical trials & new drugs Violeta Valcheva Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria Synthesis, cytotoxic evaluation and biological activities of some novel sulfonylhydrazones and 4-methyl-1,2,3-thiadiazole based hydrazone derivatives as antimycobacterial agents P02 Clinical trials & new drugs Valcheva Synthesis, cytotoxic evaluation and biological activities of some novel sulfonylhydrazones and 4-methyl-1,2,3-thiadiazole based hydrazone derivatives as antimycobacterial agents
P03 Clinical trials & new drugs Agnieszka Knast Laboratory of Genetics and Physiology of Mycobacterium, Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland. The evaluation of the level of natural selection on rpoB gene P03 Clinical trials & new drugs Knast The evaluation of the level of natural selection on rpoB gene
P04 Clinical trials & new drugs Francesco Bisognin University of Bologna MYCO-TB: the first IVD kit suitable for the digestion and decontamination of extra-pulmonary specimens to detect Mycobacteria P04 Clinical trials & new drugs Bisognin MYCO-TB: the first IVD kit suitable for the digestion and decontamination of extra-pulmonary specimens to detect Mycobacteria
P05 Clinical trials & new drugs Egor Shitikov Research and Clinical Center of Physical-Chemical Medicine, Malaya Pirogovskaya Str. 1a, Moscow 119435, Russia Transcriptomic profile of Mycobacterium smegmatis in response to the G-quadruplex ligand BRACO-19. P05 Clinical trials & new drugs Shitikov Transcriptomic profile of Mycobacterium smegmatis in response to the G-quadruplex ligand BRACO-19.
P06 Diagnostics David Rodriguez Temporal Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain Reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification: a multi-centre study P06 Diagnostics Rodriguez Temporal Reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification: a multi-centre study
P07 Diagnostics Kamal Shrivastava Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India Analysis of PE-PPE gene family: Search for a novel diagnostic target for M. tuberculosis complex P07 Diagnostics Shrivastava Analysis of PE-PPE gene family: Search for a novel diagnostic target for M. tuberculosis complex
P08 Diagnostics


Anvita

Gupta Malhotra AIl India Institute of Medical Sciences, Bhopal (M.P) - INDIA Implementation of Xpert MTB/RIF Ultra for the rapid diagnosis of Extrapulmonary Tuberculosis in low-income high-tuberculosis prevalence settings P08 Diagnostics Singh Implementation of Xpert MTB/RIF Ultra for the rapid diagnosis of Extrapulmonary Tuberculosis in low-income high-tuberculosis prevalence settings
P09 Diagnostics Derek Conkle-Gutierrez San Diego State University In silico identification of novel compensatory mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates points to Higher than previously thought prevalence of compensation P09 Diagnostics Valafar In silico identification of novel compensatory mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates points to Higher than previously thought prevalence of compensation
P10 Drug resistance Vijay Srinivasan Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom Developing a killing assay for quantitative determination of tolerance to rifampicin in Mycobacterium tuberculosis. P10 Drug resistance Srinivasan Developing a killing assay for quantitative determination of tolerance to rifampicin in Mycobacterium tuberculosis.
P11 Drug resistance Deisy Rocha Silva Life and Health Sciences Research Institute, School of Medicine, University of Minho, Portugal Different levels of streptomycin resistance found in genetically similar clinical isolates of M. tuberculosis P11 Drug resistance Rocha Silva Different levels of streptomycin resistance found in genetically similar clinical isolates of M. tuberculosis
P12 Drug resistance Hassan Shatub Cukurova University, Medicine Faculty, Medical Microbiology Department Comparison of gene expression profiles between high and low dose Isoniazid resistance in multidrug resistant Mycobacterium tuberculosis P12 Drug resistance Yakici Comparison of gene expression profiles between high and low dose Isoniazid resistance in multidrug resistant Mycobacterium tuberculosis
P13 Drug resistance  Nelly Ciobanu Institute of Phthisiopneumology, Chisinau, Moldova Diagnostic accuracy of the of molecular tests for early diagnosis of multidrug-resistant tuberculosis P13 Drug resistance Crudu Diagnostic accuracy of the of molecular tests for early diagnosis of multidrug-resistant tuberculosis
P14 Drug resistance Simone Battaglia IRCCS San Raffael Scientific Institute, Milan, Italy Lineage 1 has elevated pyrazinamide minimum inhibitory concentrations compared with other lineages of Mycobacterium tuberculosis complex P14 Drug resistance Battaglia Lineage 1 has elevated pyrazinamide minimum inhibitory concentrations compared with other lineages of Mycobacterium tuberculosis complex
P15 Host pathogen interaction Susanne Homolka Research Center Borstel, Molecular and Experimental Mycobacteriology, Borstel, Germany Three-dimensional topographic structure of Mycobacterium canettii strains - an atomic force microscopy approach P15 Host pathogen interaction Homolka Three-dimensional topographic structure of Mycobacterium canettii strains - an atomic force microscopy approach
P16 Host pathogen interaction Pere-Joan Cardona Unitat de Tuberculosi Experimental. Institut de Recerca Germans Trias i Pujol (IGTP) The origin and maintenance of tuberculosis is explained by its subclinical course, the Neolithic revolution being the trigger for its devastaging deadly drift. P16 Host pathogen interaction Cardona The origin and maintenance of tuberculosis is explained by its subclinical course, the Neolithic revolution being the trigger for its devastaging deadly drift.
P17 Host pathogen interaction Faramarz Valafar San Diego State University Integrative analyses of DNA methylomes reveals intercellular mosaic methylation as a source of differential phenotypic plasticity between MTBC clinical strains P17 Host pathogen interaction Valafar Integrative analyses of DNA methylomes reveals intercellular mosaic methylation as a source of differential phenotypic plasticity between MTBC clinical strains
P18 Host pathogen interaction Morgane Mitermite University College Dublin Investigating the role of MPB70 in mycobacterial-macrophage interactions P18 Host pathogen interaction Mitermite Investigating the role of MPB70 in mycobacterial-macrophage interactions
P19 Host pathogen interaction Ruoyao Ma UCD School of Veterinary Medicine, University College Dublin, Ireland Exploring the role of the TbD1 locus in Mycobacterium bovis P19 Host pathogen interaction Ma Exploring the role of the TbD1 locus in Mycobacterium bovis
P20 Host pathogen interaction Guillem Santamaria Aguilar Facultade de Ciências da Universidade de Lisboa Decyphering Mycobacterium tuberculosis host specificity through the integration of genomics and infection biology P20 Host pathogen interaction Santamaria Aguilar Decyphering Mycobacterium tuberculosis host specificity through the integration of genomics and infection biology
P21 Host pathogen interaction Carlos Gomis Olcina Institute for Integrative Systems Biology (UV-CSIC), España Favored infections with Mycobacterium tuberculosis lineages infecting animal and human cells induce higher necrosis levels. P21 Host pathogen interaction Gomis Olcina Favored infections with Mycobacterium tuberculosis lineages infecting animal and human cells induce higher necrosis levels.
P22 Host pathogen interaction Robin Skuce Agrifood and Biosciences Institute, Belfast UK Descriptive summary of Mycobacterium bovis genotypes in cattle and badgers in a wildlife intervention research area (2014-2018). P22 Host pathogen interaction Skuce Descriptive summary of Mycobacterium bovis genotypes in cattle and badgers in a wildlife intervention research area (2014-2018).
P23 Host pathogen interaction Gladys Maria Pangga College of Veterinary Medicine, University of the Philippines Los Baños, Laguna, Philippines In search of novel lineages within the Mycobacterium tuberculosis complex (MTBc) P23 Host pathogen interaction Pangga In search of novel lineages within the Mycobacterium tuberculosis complex (MTBc)
P24 Host pathogen interaction Lidia Zukowska The Bio-Med-Chem Doctoral School of the University of Lodz and Lodz Institutes of the Polish Academy of Sciences, Lodz, Poland Mycobacterium tuberculosis lineages involved in outbreaks worldwide P24 Host pathogen interaction Zukowska Mycobacterium tuberculosis lineages involved in outbreaks worldwide
P25 Host pathogen interaction Esther Julian   The outermost surface of BCG substrains is conditioned by growth media P25 Host pathogen interaction Julian The outermost surface of BCG substrains is conditioned by growth media
P26 Host pathogen interaction Matteo Chiacchiaretta Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano, Italy Interplay between macrophage polarization and M. tuberculosis lineages P26 Host pathogen interaction Chiacchiaretta Interplay between macrophage polarization and M. tuberculosis lineages
P27 Host pathogen interaction sonia Borrell Swiss TPH. University of Basel Proteomic and transcriptomic characterization of fully sequenced diverse Lineage 1 and Lineage 2 clinical isolates of M.tuberculosis P27 Host pathogen interaction Borrell Proteomic and transcriptomic characterization of fully sequenced diverse Lineage 1 and Lineage 2 clinical isolates of M.tuberculosis
P29 Molecular epidemiology Sofia Samper Instituto Aragonés de Ciencias de la Salud Identification of specific characteristics in Mycobacterium africanum Lineage 6, a lineage that occurs in a low frequency in Spain P29 Molecular epidemiology Samper Identification of specific characteristics in Mycobacterium africanum Lineage 6, a lineage that occurs in a low frequency in Spain
P30 Molecular epidemiology Andrea M. Cabibbe San Raffaele Scientific Institute In vitro characterization of a successful multidrug-resistant Mycobacterium tuberculosis clone actively transmitted in Italy P30 Molecular epidemiology Cabibbe In vitro characterization of a successful multidrug-resistant Mycobacterium tuberculosis clone actively transmitted in Italy
P31 Molecular epidemiology Egor Shitikov Research and Clinical Center of Physical-Chemical Medicine, Malaya Pirogovskaya Str. 1a, Moscow 119435, Russia A comprehensive map of Mycobacterium tuberculosis complex regions of difference. P31 Molecular epidemiology Shitikov A comprehensive map of Mycobacterium tuberculosis complex regions of difference.
P32 Molecular epidemiology David Couvin WHO Supranational TB Reference Laboratory – TB & Mycobacteria Unit, Institut Pasteur de Guadeloupe, 97183 Abymes, Guadeloupe, France SITVITBovis - a publicly available database and mapping tool to get an improved overview of animal and human cases caused by Mycobacterium bovis P32 Molecular epidemiology Couvin SITVITBovis - a publicly available database and mapping tool to get an improved overview of animal and human cases caused by Mycobacterium bovis
P33 Molecular epidemiology Carlos Francisco Madrazo Moya Tuberculosis Genomics Unit. Inst. de Biomedicina de Valencia (IBV-CSIC) Five years of tuberculosis molecular epidemiology in Valencia, Spain. P33 Molecular epidemiology Madrazo Moya Five years of tuberculosis molecular epidemiology in Valencia, Spain.
P34 Molecular epidemiology Mariana Gabriela López Instituto de Biomedicina de Valencia (IBV-CSIC) Comparative transmission dynamics in low and high tuberculosis burden settings P34 Molecular epidemiology López Comparative transmission dynamics in low and high tuberculosis burden settings
P35 Molecular epidemiology Thomas Kohl Research Center Borstel PHIMS-TB: Implementation of public health integrated molecular tuberculosis surveillance in Germany P35 Molecular epidemiology Kohl PHIMS-TB: Implementation of public health integrated molecular tuberculosis surveillance in Germany
P36 Molecular epidemiology Anna Vyazovaya St. Petersburg Pasteur Institute Changes in population structure of Mycobacterium tuberculosis in northern Russia over 13 years P36 Molecular epidemiology Vyazovaya Changes in population structure of Mycobacterium tuberculosis in northern Russia over 13 years
P37 Molecular epidemiology Darja Sadovska Latvian Biomedical Research and Study Centre WGS-based recurrent tuberculosis cause determination for patients involved in local outbreaks in Latvia P37 Molecular epidemiology Sadovska WGS-based recurrent tuberculosis cause determination for patients involved in local outbreaks in Latvia
P38 Molecular epidemiology Alena Gerasimova Institut Pasteur Increasing proportion of strains of ancient sublineage of the Mycobacterium tuberculosis Beijing genotype among patients with HIV-tuberculosis coinfection P38 Molecular epidemiology Gerasimova Increasing proportion of strains of ancient sublineage of the Mycobacterium tuberculosis Beijing genotype among patients with HIV-tuberculosis coinfection
P39 Molecular epidemiology Pauline Lempens Institute of Tropical Medicine Antwerp Multidrug-resistant tuberculosis (MDR-TB) transmission in Bangladesh: what can we learn from a whole genome sequencing based clustering approach? P39 Molecular epidemiology Lempens Multidrug-resistant tuberculosis (MDR-TB) transmission in Bangladesh: what can we learn from a whole genome sequencing based clustering approach?
P40 Molecular epidemiology Belén Saavedra Cervera Barcelona Institute for Global Health (ISGlobal) Study on the population structure and transmission patterns of Mycobacterium tuberculosis in Southern Mozambique: Unraveling the local epidemic P40 Molecular epidemiology Saavedra Cervera Study on the population structure and transmission patterns of Mycobacterium tuberculosis in Southern Mozambique: Unraveling the local epidemic
P41 New frontier in next generation sequencing Anzaan Dippenaar Stellenbosch University Identifying optimal chemical liquefaction and decontamination of sputum and assessing time to culture positivity for Mycobacterium tuberculosis P41 New frontier in next generation sequencing Dippenaar Identifying optimal chemical liquefaction and decontamination of sputum and assessing time to culture positivity for Mycobacterium tuberculosis
P42 New frontier in next generation sequencing Conor Meehan University of Bradford How reliable is spoligotyping for (sub-)lineage prediction within the Mycobacterium tuberculosis complex? P42 New frontier in next generation sequencing Meehan How reliable is spoligotyping for (sub-)lineage prediction within the Mycobacterium tuberculosis complex?
P43 New frontier in next generation sequencing Teresa Cortes London School of Hygiene and Tropical Medicine A snapshot of translation in Mycobacterium tuberculosis during exponential growth and nutrient starvation revealed by ribosome profiling P43 New frontier in next generation sequencing Cortes A snapshot of translation in Mycobacterium tuberculosis during exponential growth and nutrient starvation revealed by ribosome profiling
P44 New frontier in next generation sequencing Adrian Allen Agrifood and Biosciences Institute, Belfast, UK Genomic epidemiology of Mycobacterium bovis infection in sympatric badger and cattle populations in Northern Ireland. P44 New frontier in next generation sequencing Allen Genomic epidemiology of Mycobacterium bovis infection in sympatric badger and cattle populations in Northern Ireland.
P45 New frontier in next generation sequencing Viktor Perets UCD School of Veterinary Medicine, University College Dublin, Dublin 4, Ireland Evidence for local and international spread of Mycobacterium avium subspecies paratuberculosis through whole genome sequencing of isolates from the island of Ireland P45 New frontier in next generation sequencing Perets Evidence for local and international spread of Mycobacterium avium subspecies paratuberculosis through whole genome sequencing of isolates from the island of Ireland
P46 New frontier in next generation sequencing Carla Mariner Llicer Instituto de Biomedicina de Valencia (CSIC) Assessing Direct Whole Genome Sequencing feasibility from clinical samples in high-burden tuberculosis countries P46 New frontier in next generation sequencing Mariner Llicer Assessing Direct Whole Genome Sequencing feasibility from clinical samples in high-burden tuberculosis countries
P47 New frontier in next generation sequencing Violeta Valcheva Institute of microbiology, Bulgarian Academy of Sciences First insight into whole genome sequencing of Mycobacterium bovis isolated from cattle in Bulgaria P47 New frontier in next generation sequencing Valcheva First insight into whole genome sequencing of Mycobacterium bovis isolated from cattle in Bulgaria
P48 New frontier in next generation sequencing Christophe Sola 2Université Paris-Saclay, Saint-Aubin, France Description of a new ancestral lineage of the L2 Mycobacterium tuberculosis complex in Japan and Revision of the current L2 Lineage/sublineage nomenclature P48 New frontier in next generation sequencing Sola Description of a new ancestral lineage of the L2 Mycobacterium tuberculosis complex in Japan and Revision of the current L2 Lineage/sublineage nomenclature
P49 New frontier in next generation sequencing Charlotte Genestet CIRI - Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308 Comparison of three methods of Mycobacterium tuberculosis complex spoligotype determination for clinical isolates, Lyon, France P49 New frontier in next generation sequencing Genestet Comparison of three methods of Mycobacterium tuberculosis complex spoligotype determination for clinical isolates, Lyon, France
P50 NTM Daria Neronskaya St. Petersburg Pasteur Institute Drag resistance of Mycobacterium avium complex clinical isolates P50 NTM Neronskaya Drag resistance of Mycobacterium avium complex clinical isolates
P51 NTM Eva Sodja University Clinic Golnik, Laboratory for Mycobacteria Performance of MALDI-TOF mass spectrometry in determination of diffucult to identfy non-tuberculous mycobacterial species P51 NTM Sodja Performance of MALDI-TOF mass spectrometry in determination of diffucult to identfy non-tuberculous mycobacterial species
P52 NTM Sahal Al-Hojoj Al-Nakhli   Is Mycobacterium riyadhense, an Emerging, Slow-Growing Species of Nontuberculous Mycobacteria in a constant evolution towards possible pathogenicity? P52 NTM Al-Hojoj Al-Nakhli Is Mycobacterium riyadhense, an Emerging, Slow-Growing Species of Nontuberculous Mycobacteria in a constant evolution towards possible pathogenicity?
P54 NTM Emma Roycroft Irish Mycobacteria Reference Laboratory Mycobacterium avium subspecies paratuberculosis: are we missing something? P54 NTM Roycroft Mycobacterium avium subspecies paratuberculosis: are we missing something?
P55 NTM Amelia Assuncao FP-ENAS/CEBIMED (Biomedical Research Center), Universidade Fernando Pessoa, Porto, Portugal Patients with Crohn's disease or liver cirrhosis show increased frequency of viable Mycobacterium avium subsp. paratuberculosis P55 NTM Assuncao Patients with Crohn's disease or liver cirrhosis show increased frequency of viable Mycobacterium avium subsp. paratuberculosis
P56 NTM Filip Gasior Laboratory of Genetics and Physiology of Mycobacterium, Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland Determination of the Msmeg_1891 role in response to DNA damage in M. smegmatis. P56 NTM Gasior Determination of the Msmeg_1891 role in response to DNA damage in M. smegmatis.
P57 NTM Leen Rigouts BCCM/ITM Collection of mycobacterial cultures Mycobacterial cultures survive long-term storage at -20°C in sterile distilled water and multiple cycles of freezing/thawing. P57 NTM Rigouts Mycobacterial cultures survive long-term storage at -20°C in sterile distilled water and multiple cycles of freezing/thawing.
P58 NTM Patrícia Graça Hans-Knöll- Institute Biosynthesis and structure of the redox cofactor mycofactocin in Mycolicibacterium smegmatis P58 NTM Graça Biosynthesis and structure of the redox cofactor mycofactocin in Mycolicibacterium smegmatis
P60 Other Samuel Modlin San Diego State University A lineage-specific ClpC1 missense mutation provides a mechanistically plausible basis for the abnormally high prevalence of PZA mono-resistance in the Indo-Oceanic lineage P60 Other Valafar A lineage-specific ClpC1 missense mutation provides a mechanistically plausible basis for the abnormally high prevalence of PZA mono-resistance in the Indo-Oceanic lineage
P61 Other Chantal Renau I2SysBio, University of Valencia-FISABIO Joint Unit, Valencia, Spain New insights in the genome content of the bacterium Mycobacterium brumae P61 Other Renau New insights in the genome content of the bacterium Mycobacterium brumae
P62 Other Stefan Panaiotov National Center of Infectious and Parasitic Diseases Complete genome sequence, genome stability and phylogeny of the vaccine strain Mycobacterium bovis BCG SL222 Sofia P62 Other Panaiotov Complete genome sequence, genome stability and phylogeny of the vaccine strain Mycobacterium bovis BCG SL222 Sofia
P63 Other Renate Ranka Latvian Biomedical Research and Study Centre Mycobacterial diversity in archaeological samples from Iron Age (7th – 12th centuries AD) burials in Latvia. P63 Other Ranka Mycobacterial diversity in archaeological samples from Iron Age (7th – 12th centuries AD) burials in Latvia.
P64 Diagnostics Syn Yu Chua Singapore General Hospital Validation of Mycobacteria Detection using the Copan ESwab P64 Diagnostics Chua Validation of Mycobacteria Detection using the Copan ESwab
P65 Drug resistance Jitendra Singh All India Institute of Medical Sciences, Bhopal Drug Resistant Tuberculosis in Wildlife: A threat to Combat P65 Drug resistance Singh Drug Resistant Tuberculosis in Wildlife: A threat to Combat